Close Menu

NEW YORK – Foundation Medicine and Chugai Pharmaceutical said Thursday they have entered into an agreement with the National Cancer Center Japan to use Foundation's liquid biopsy test as part of an initiative targeting advanced cancer patients.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.